What are the opening hours?

Monday 08:30 - 18:00 Tuesday 08:30 - 18:00 Wednesday 08:30 - 18:00 Thursday 08:30 - 18:00 Friday 08:30 - 18:00

arigo biolaboratories Corp.

Name: arigo biolaboratories Corp.
Address: 竹北市台元二街12號9樓之 7, Hsinchu, 302082, TW
Telephone: +88635621738

Home
Taiwan
Hsinchu
arigo biolaboratories Corp.

Call Directions Website

nuts about antibodies.

29/09/2026

NRF2 Puzzle-2：Redox Homeostasis

Nrf2 is a master regulator of cellular antioxidant defense. In addition to promoting ROS detoxification through NQO1 and HO-1, Nrf2 regulates cellular redox homeostasis through the NADPH-GSH-TRX axis. arigo offers Keap1-Nrf2-ARE (ARG30345) and a series of research tools to support advanced studies of Nrf2 signaling and NADPH-GSH-TRX axis.

Learn more at arigobio.com/news/keap1-nrf2-are

22/09/2026

NRF2 Puzzle-1：ROS Detoxification

Nrf2 is a key regulator of cellular antioxidant defense. Under normal conditions, Keap1 promotes Nrf2 degradation. Under oxidative stress, Nrf2 escapes Keap1-mediated degradation, accumulates in the nucleus, and induces NQO1, HO-1, and other antioxidant proteins. Nrf2 also promotes LC3B and SQSTM1 expression, facilitating Keap1 autophagic degradation and amplifying antioxidant defense.

arigo offers Keap1-Nrf2-ARE (ARG30345) and Autophagy (ARG30321) Antibody Panels, designed to facilitate research into the Keap1/Nrf2/ARE pathway and its interplay with autophagy.

Learn more at arigobio.com/news/keap1-nrf2-are

15/09/2026

GainData® cited in Nature again

arigo is pleased to announce that GainData®, our free ELISA calculator, has been cited in Nature again! (PMID: 41882353)

GainData®, developed by arigo, is a FREE web service designed to simplify ELISA data analysis. Simply copy and paste your raw data to perform ELISA curve fitting and easily obtain exportable results.

GainData® is not restricted to ELISA data analysis, it is also useful for analyzing the data of a variety of assay kits.

Try GainData® now and make your data analysis easier!
www.arigobio.com/elisa-calculator

Selected Citations of GainData®
Kleeman et al., (2026) Nature. 653(8116):1216-1228.
Hussien et al., (2026) Nat Commun. 17(1):3893.
de Souza et al., (2024) Brain Behav Immun. 116:193-202.
Tang et al., (2022) Nat Med. 28(7):1372-1376.
Ma et al., (2022) Nature. 603(7899):159-165.
Zhang et al., (2022) Nat Metab. 4(10):1369-1401.
Ayloo et al., (2022) Neuron. 110(10):1641-1655.

®

08/09/2026

arigo is pleased to announce that our IL-5 antibody (ARG66000) has been used in the validation of IL-5 CAR-T cell therapy reported in the Journal of Hematology & Oncology (IF: 47.8).

arigo offers a series of quality control and validation kits designed to support CAR-T cell generation, characterization, and evaluation. Our solutions help researchers achieve reliable performance assessment throughout the CAR-T development workflow, from early-stage engineering to preclinical validation.

Learn more at arigobio.com/news/cell-therapy

01/09/2026

Tumor-derived exosomal HMGB1 is associated with poor prognosis by promoting tumor progression, immunosuppression, and therapy resistance. In NSCLC and ESCC, exosomal HMGB1 drives M2 polarization to promote immune evasion. These findings highlight exosomal HMGB1 as a promising prognostic biomarker and therapeutic target.

arigo offers reliable ELISA kits for exosomal HMGB1 quantification, and comprehensive research tools for M1/M2 macrophage polarization, supporting investigations into the role of exosomal HMGB1 in M2 polarization.

Learn more at arigobio.com/hmgb1-elisa-kits

25/08/2026

JAK-STAT signaling plays a critical role in regulating the differentiation of CD4+ T cell subsets, including Th1, Th2, Th17, and Treg cells. STAT1 and STAT4 drive Th1 differentiation, STAT6 promotes Th2 differentiation, and STAT3 and STAT5 regulate the differentiation of Th17 and Treg cells, respectively. arigo offers quality antibodies and multiplex ELISA kits to support the investigation of JAK–STAT signaling and its role in maintaining Th1/Th2/Th17/Treg immune balance.

Learn more at arigobio.com/news/th-multiplex-elisa-kit

18/08/2026

arigo is pleased to announce that our Collagen IV antibody (ARG21968) was cited in a recent Advanced Science publication. Yu et al. used this pre-adsorbed antibody with specific and clean staining to assess basement membrane integrity (PMID: 41824788).

Collagen IV antibodies are widely used to evaluate basement membrane disruption associated with tumor invasion, metastasis, and angiogenesis. arigo provides reliable Collagen IV antibodies with high specificity for histological metastasis research.

Learn more at arigobio.com/search?search_type=1&keyword=collagen%20iv

11/08/2026

arigo is proud to announce that our Collagen II antibody (ARG20787) was cited in a recent Nature Communications publication. Liu et al. developed a sandwich-layered hydrogel scaffold for osteochondral regeneration and used arigo’s Collagen II antibody to demonstrate enhanced in vitro chondrogenic differentiation and in vivo osteochondral repair. (PMID: 41997947)

Collagen II is a key biomarker for evaluating cartilage regeneration and repair. arigo provides quality Collagen II antibodies to support research advancing the field of osteochondral regeneration.

Learn more at arigobio.com/search?search_type=1&keyword=collagen%20ii

04/08/2026

is pleased to announce that our Collagen I (ARG21965) and Collagen III (ARG20786) antibodies have been cited in research related to anterior cruciate ligament (ACL) reconstruction. Lo et al. investigated the therapeutic potential of exosomes derived from a coculture of ACL remnant cells and bone marrow stromal cells. Their findings demonstrated that these exosomes enhanced tenocyte function and survival, highlighting their potential to improve healing outcomes after ACL reconstruction. (PMID: 41578922)

Learn more at
arigobio.com/anti-Collagen-I-antibody-pre-adsorbed-ARG21965.html
arigobio.com/anti-Collagen-III-antibody-pre-adsorbed-ARG20786.html

28/07/2026

HBV infection is one of the leading causes of chronic hepatic inflammation that progress to cirrhosis and hepatocellular carcinoma (HCC). Understanding the molecular mechanisms of viral proteins is critical for developing effective therapeutic approaches strategies against HBV-related HCC. arigo offers a series of HBV-specific antibodies to support and advance related research.

Learn more at arigobio.com/hbv

Address

竹北市台元二街12號9樓之 7
Hsinchu
302082

Opening Hours

Monday	08:30 - 18:00
Tuesday	08:30 - 18:00
Wednesday	08:30 - 18:00
Thursday	08:30 - 18:00
Friday	08:30 - 18:00

Telephone

+88635621738

Website

http://www.arigobio.com/

Alerts

Be the first to know and let us send you an email when arigo biolaboratories Corp. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.